MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.esmoop.2026.108339

Медицинская библиотека · ESMO open · 2026

MYC rearrangement improves the predictive efficacy of the double-hit model in newly diagnosed multiple myeloma.

Zhao J, Du C, Cui J, Li L, Zheng Y, Zhang W, Guo X, Deng S, Xu Y, Sui W, Huang W, Liu W, Zou D, Qiu L, Sun Q, Li C, Xiao Z, An G

Клиническое исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

MYC rearrangement (MYC-R) is a known adverse prognostic factor in multiple myeloma (MM), yet its role in the double-hit model remains undefined. Meanwhile, the prognostic value of MYC gain/amp has not been clearly characterized. This study aimed to evaluate the prognostic impact of MYC-R and/or gain/amp to assess their potential role in refining risk stratification.

PATIENTS AND

METHODS

A prospective cohort of 227 patients with newly diagnosed MM (enrolled in the NICHE clinical trial, NCT04645199) received bortezomib-based induction therapy and, if eligible, underwent upfront autologous stem cell transplantation. The FISH panel included del(13q), del(17p), del(1p), 1q21 gain/amp, IgH rearrangement, t(4;14), t(11;14), t(14;16), t(14;20), MYC break-apart probe, and IgH/MYC fusion probe.

RESULTS

Median progression-free survival (PFS) was significantly shorter in patients with MYC-R (34.0 months) or MYC gain/amp (34.3 months), compared with those without MYC abnormalities (49.2 months; P = 0.003 and 0.016, respectively). IgH/MYC was notably more common in cases with undefined-partner IgH translocations (16.6%) than those with defined partners (5.7%), and was associated with poorer outcomes. In multivariate analysis, MYC-R remained an independent predictor of PFS (hazard ratio 1.96, P = 0.007) and improved the discriminative performance of the double-hit model by increasing the concordance index for PFS from 0.549 to 0.581.

CONCLUSION

Both MYC-R and MYC gain/amp indicate adverse prognosis in newly diagnosed MM. The independent prognostic value of MYC-R supports its integration into routine FISH panels and future refinements of the double-hit risk model.

Для цитирования: Zhao J, Du C, Cui J, Li L, Zheng Y, Zhang W, Guo X, Deng S, Xu Y, Sui W, Huang W, Liu W, Zou D, Qiu L, Sun Q, Li C, Xiao Z, An G. MYC rearrangement improves the predictive efficacy of the double-hit model in newly diagnosed multiple myeloma.. ESMO open. 2026. DOI: 10.1016/j.esmoop.2026.108339.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.